Results 131 to 140 of about 798 (156)
Some of the next articles are maybe not open access.
Journal of Neuro-Oncology, 1999
Clinical trials of boron neutron capture therapy (BNCT) for glioblastoma multiforme are currently in progress using p-boronophenylalanine (BPA) as the 10B delivery agent. Enhancement of tumor boron uptake and/or the tumor-to-blood (T:B) boron concentration ratio would have the potential of significantly improving the therapeutic gain of BNCT.
D D, Joel +3 more
openaire +2 more sources
Clinical trials of boron neutron capture therapy (BNCT) for glioblastoma multiforme are currently in progress using p-boronophenylalanine (BPA) as the 10B delivery agent. Enhancement of tumor boron uptake and/or the tumor-to-blood (T:B) boron concentration ratio would have the potential of significantly improving the therapeutic gain of BNCT.
D D, Joel +3 more
openaire +2 more sources
Journal of Neuro-Oncology, 2000
Twelve normal dogs underwent brain irradiation in a mixed-radiation, mainly epithermal neutron field at the Brookhaven Medical Research Reactor following intravenous infusion of 950 mg of 10B-enriched BPA/kg as its fructose complex. The 5 x 10 cm irradiation aperture was centered over the left hemisphere.
J A, Coderre +7 more
openaire +2 more sources
Twelve normal dogs underwent brain irradiation in a mixed-radiation, mainly epithermal neutron field at the Brookhaven Medical Research Reactor following intravenous infusion of 950 mg of 10B-enriched BPA/kg as its fructose complex. The 5 x 10 cm irradiation aperture was centered over the left hemisphere.
J A, Coderre +7 more
openaire +2 more sources
Bioavailability of Intravenous Formulations of P-Boronophenylalanine in Dog and Rat
1993Boron neutron capture therapy (BNCT) is being developed as a treatment for malignant melanoma. P-boronophenyialanine (BPA) was initially proposed as a boron (B) delivery drug for BNCT of malignant melanoma because it was postulated that this B-containing amino acid, by mimicking a melanin precursor, would selectively accumulate in melanoma cells.
T. R. LaHann +6 more
openaire +1 more source
Glioma Stem-Like Cells Can Be Targeted in Boron Neutron Capture Therapy with Boronophenylalanine
Cancers, 2020Eishu Hirata +2 more
exaly
International Journal of Radiation Oncology Biology Physics, 1994
B J Allen, D E Moore, Douglas E Moore
exaly
B J Allen, D E Moore, Douglas E Moore
exaly

